Core idea
From concept to management action.
Pharmacy strategy becomes manageable when net cost, clinical access and every compensation stream are visible together.
Pharmacy is often treated as a carve-out or a renewal exhibit, but it is a year-round purchasing and care decision. A plan sponsor needs a net-cost view that connects ingredient cost, dispensing, rebates, specialty distribution, administration and the member experience.
Ask how every party is paid. Retail spread, retained rebates, affiliate relationships, manufacturer payments and specialty margins may affect the economic result. Transparency is not an accusation; it is the basis for evaluating whether incentives and contractual commitments align with plan objectives.
Specialty medications, GLP-1s and biosimilars deserve explicit strategy. Leadership should understand covered indications, clinical criteria, sourcing options, continuity concerns and the implementation support available to members and prescribers.
Audit rights and guarantees make commitments governable. Define the data, methodology, timing, remedies and independent review rights before relying on a reported savings result. Review performance through the year instead of waiting for an annual reconciliation.
Start with a pharmacy dashboard that shows net cost, specialty share, top therapy movement, rebate reconciliation, utilization-management outcomes and member disruption. Give each measure an owner and a decision purpose.
tools